APA (7th ed.) Citation

JY, W., KW, L., SC, H., HY, C., & YM, L. (2026). Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: A real-world cohort study. Frontiers in medicine, 13, 1820366. https://doi.org/10.3389/fmed.2026.1820366

Chicago Style (17th ed.) Citation

JY, Wu, Lee KW, Huang SC, Chang HY, and Lin YM. "Comparative Effectiveness of Tirzepatide Versus GLP-1 Receptor Agonists on the Risk of Venous Thromboembolism in Patients with Obesity: A Real-world Cohort Study." Frontiers in Medicine 13 (2026): 1820366. https://doi.org/10.3389/fmed.2026.1820366.

MLA (9th ed.) Citation

JY, Wu, et al. "Comparative Effectiveness of Tirzepatide Versus GLP-1 Receptor Agonists on the Risk of Venous Thromboembolism in Patients with Obesity: A Real-world Cohort Study." Frontiers in Medicine, vol. 13, 2026, p. 1820366, https://doi.org/10.3389/fmed.2026.1820366.